The Manufacturers Life Insurance Company Sells 17,860 Shares of Welltower Inc. $WELL

The Manufacturers Life Insurance Company reduced its stake in Welltower Inc. (NYSE:WELL) by 4.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 403,898 shares of the real estate investment trust’s stock after selling 17,860 shares during the period. The Manufacturers Life Insurance Company owned approximately 0.06% of Welltower worth $91,673,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Revolve Wealth Partners LLC grew its position in Welltower by 3.3% during the 2nd quarter. Revolve Wealth Partners LLC now owns 1,392 shares of the real estate investment trust’s stock valued at $316,000 after purchasing an additional 45 shares during the last quarter. Cornerstone Financial Management LLC grew its holdings in shares of Welltower by 3.5% during the second quarter. Cornerstone Financial Management LLC now owns 1,318 shares of the real estate investment trust’s stock valued at $299,000 after buying an additional 45 shares during the last quarter. Family Wealth Partners LLC grew its holdings in shares of Welltower by 1.3% during the second quarter. Family Wealth Partners LLC now owns 3,678 shares of the real estate investment trust’s stock valued at $835,000 after buying an additional 48 shares during the last quarter. Natural Investments LLC increased its position in shares of Welltower by 3.0% during the second quarter. Natural Investments LLC now owns 1,673 shares of the real estate investment trust’s stock valued at $379,000 after acquiring an additional 48 shares in the last quarter. Finally, West Family Investments Inc. increased its position in shares of Welltower by 1.9% during the second quarter. West Family Investments Inc. now owns 2,569 shares of the real estate investment trust’s stock valued at $583,000 after acquiring an additional 48 shares in the last quarter. 94.80% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

WELL has been the topic of several analyst reports. Barclays upped their price objective on Welltower from $254.00 to $259.00 and gave the company an “equal weight” rating in a research report on Monday, August 31st. Royal Bank Of Canada raised their price target on shares of Welltower from $238.00 to $260.00 and gave the company an “outperform” rating in a report on Monday, August 3rd. Raymond James Financial assumed coverage on shares of Welltower in a research note on Tuesday, June 16th. They issued an “outperform” rating and a $226.00 price target for the company. Cantor Fitzgerald boosted their price objective on shares of Welltower from $235.00 to $260.00 and gave the company an “overweight” rating in a report on Friday, July 31st. Finally, Wells Fargo & Company increased their price objective on shares of Welltower from $237.00 to $266.00 and gave the company an “overweight” rating in a research report on Tuesday, September 1st. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $251.06.

Welltower Trading Down 0.1%

Welltower stock opened at $235.44 on Friday. Welltower Inc. has a 52-week low of $163.75 and a 52-week high of $255.20. The company has a market cap of $169.69 billion, a P/E ratio of 108.00, a P/E/G ratio of 1.13 and a beta of 0.76. The company has a quick ratio of 3.16, a current ratio of 3.16 and a debt-to-equity ratio of 0.37. The business has a 50-day simple moving average of $237.86 and a two-hundred day simple moving average of $219.68.

Welltower (NYSE:WELL) last issued its quarterly earnings data on Monday, July 27th. The real estate investment trust reported $0.61 earnings per share for the quarter, missing the consensus estimate of $0.66 by ($0.05). The business had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.40 billion. Welltower had a return on equity of 3.56% and a net margin of 12.15%.Welltower’s revenue for the quarter was up 39.1% on a year-over-year basis. During the same quarter last year, the company earned $1.28 EPS. Welltower has set its FY 2026 guidance at 6.360-6.440 EPS. Analysts predict that Welltower Inc. will post 6.43 EPS for the current year.

Welltower Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 20th. Stockholders of record on Wednesday, August 12th were given a dividend of $0.85 per share. This represents a $3.40 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend was Wednesday, August 12th. This is a positive change from Welltower’s previous quarterly dividend of $0.74. Welltower’s payout ratio is presently 155.96%.

Insider Activity

In related news, Director Andrew Gundlach acquired 5,000 shares of Welltower stock in a transaction dated Tuesday, August 25th. The stock was purchased at an average cost of $239.47 per share, for a total transaction of $1,197,350.00. Following the purchase, the director directly owned 25,000 shares of the company’s stock, valued at approximately $5,986,750. This trade represents a 25.00% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. 0.37% of the stock is currently owned by insiders.

Welltower Company Profile

Welltower Inc is a real estate investment trust (REIT) that owns, operates and finances healthcare-related real estate. The company focuses on properties that support healthcare delivery and services, including senior housing communities, outpatient medical facilities and post-acute care properties.

Welltower partners with healthcare providers, senior housing operators and other service providers to develop and manage facilities designed to serve aging populations and patients requiring ongoing or specialized care.